{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/67105af848726944170ab1fe/6a9f82f32a7730b896639834?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Palani Kumaresan: Roche Diagnostics Is Ramping Up—Should Illumina Be Worried?","description":"<p>Roche’s AXELIOS sequencer, Alzheimer’s blood test, and push to automate mass spectrometry point to a broader strategy of making advanced diagnostics routine. Whether AXELIOS can meaningfully challenge Illumina’s sequencing dominance, however, remains an open question.</p><p><br></p>","author_name":"Inside Precision Medicine"}